- 期刊
- OpenAccess
Knock Down the Disease: Recent Developments in RNA Interference for Treatment of Cardiac Disorders
並列摘要
Genetic and acquired cardiac diseases are potential clinical targets for RNA interfering (RNAi) approaches, which are currently intensely being investigated. This review will give an update on ongoing RNAi treatment of cardiac diseases. Furthermore, small interfering RNA (siRNA) delivery systems, with special focus on cardiomyocyte uptake of siRNA, are discussed.
被引用紀錄
Lee, Z. H. (2011). PLPF: 探勘網路行為履歷於連線行為預測 [master's thesis, National Chiao Tung University]. Airiti Library. https://doi.org/10.6842/NCTU.2011.00103
延伸閱讀
- Chang, L. C., Huang, K. C., Wu, Y. W., Kao, H. L., Chen, C. L., Lai, L. P., Hwang, J. J., & Yang, W. S. (2009). The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders. Journal of the Formosan Medical Association, 108(5), 353-366. https://www.airitilibrary.com/Article/Detail?DocID=09296646-200905-108-5-353-366-a
- Lee, Y. H., Lin, P. L., Chiou, W. R., Liao, F. C., Chang, S. H., Kuo, J. Y., & Hou, C. J. Y. (2017). Non-pharmacologic Management of Structural Heart Disease. 內科學誌, 28(4), 218-222. https://doi.org/10.6314/JIMT.2017.28(4).04
- Stephen, S. L., Freestone, K., Dunn, S., Twigg, M. W., Vanniasinkam, S. H., Walker, J. H., Wheatcroft, S. B., & Ponnambalam, S. (2010). Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease. International Journal of Hypertension, 2010(), 101-121. https://doi.org/10.4061/2010/646929
- Vassiliadis, E., Barascuk, N., Didangelos, A., & Karsdal, M. A. (2012). Novel Cardiac-Specific Biomarkers and the Cardiovascular Continuum. Biomarker Insights, 2012(), 45-57. https://doi.org/10.4137/BMI.S9536
- 江福田（2001）。Gene Therapy for Cardiovascular Diseases。台灣醫學，5(1)，60-64。https://doi.org/10.6320/FJM.2001.5(1).08